Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
100 papers published this week across 6 labs.
Among intermediate-RS patients, CTX-benefit identified who derived clinically meaningful benefit from adjuvant chemotherapy, a population currently not identifiable by the RS alone.
Among intermediate-RS patients, CTX-benefit identified who derived clinically meaningful benefit from adjuvant chemotherapy, a population currently not identifiable by the RS alone.